Sanofi - ADR (SNY) gains 0.20% for July 21

Equities Staff  |

Sanofi - ADR (NASDAQ: SNY) shares gained 0.20%, or $0.1 per share, to close Wednesday at $51.50. After opening the day at $51.37, shares of Sanofi fluctuated between $51.56 and $51.14. 1,107,623 shares traded hands a decrease from their 30 day average of 1,369,146. Wednesday's activity brought Sanofi’s market cap to $129,674,089,014.

Sanofi is headquartered in Paris, Ile De France..

About Sanofi - ADR

La vocation de Sanofi est d'accompagner celles et ceux confrontés à des difficultés de santé. Entreprise biopharmaceutique mondiale spécialisée dans la santé humaine qui prévient les maladies avec ses vaccins et propose des traitements innovants. Elle accompagne tant ceux qui sont atteints de maladies rares, que les millions de personnes souffrant d'une maladie chronique. Sanofi et ses plus de 100 000 collaborateurs dans 100 pays transforment l'innovation scientifique en solutions de santé partout dans le monde. Sanofi, Empowering Life, donner toute sa force à la vie.

Visit Sanofi - ADR’s profile for more information.

About The Nasdaq Stock Market

The Nasdaq Stock Market is a global leader in trading data and services, and equities and options listing. Nasdaq is the world's leading exchange for options volume and is home to the five largest US companies - Apple, Microsoft, Amazon, Alphabet and Facebook.

To get more information on Sanofi - ADR and to follow the company’s latest updates, you can visit the company’s profile page here: Sanofi - ADR’s Profile. For more news on the financial markets be sure to visit Equities News. Also, don’t forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Chart is provided by TradingView based on 15-minute-delayed prices. All other data is provided by IEX Cloud as of 8:05 pm ET on the day of publication.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Market Movers

Sponsored Financial Content